Media coverage
5
Media coverage
Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet Las Vegas Optic Country/Territory United States Date 2/04/24 URL https://www.lasvegasoptic.com/online_features/business_and_careers/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf--trap/article_f4ce3b69-7cfa-596f-ac62-cd99948bfa0e.html Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet Mammoth Times Country/Territory United States Date 2/04/24 URL https://www.mammothtimes.com/online_features/business_and_careers/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf--trap/article_531bdb60-5d86-5b67-b7e5-e476a2f2ebce.html Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet EstesparkNews.com Country/Territory United States Date 2/04/24 URL https://www.estesparknews.com/online_features/business_and_careers/article_ca14c881-25f4-5605-a451-edea11b1aca2.html Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet Pasadena Weekly Country/Territory United States Date 2/04/24 URL https://www.pasadenaweekly.com/online_features/business_and_careers/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf--trap/article_ce6ab79a-319c-5fe2-9735-b8399056c24e.html Persons Christopher Larson Title EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting Media name/outlet Big Country News Country/Territory United States Date 2/04/24 URL https://www.bigcountrynewsconnection.com/online_features/business_and_careers/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf--trap/article_1b100c15-8e38-52f6-b2cf-14bd332a7de5.html Persons Christopher Larson